Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 22 02 2019
revised: 12 04 2019
accepted: 01 05 2019
pubmed: 22 7 2019
medline: 13 5 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

Pathological alterations to the locus coeruleus, the major source of noradrenaline in the brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI approaches now provide an opportunity to quantify structural features of the locus coeruleus in vivo during disease progression. In combination with neuropathological biomarkers, in vivo locus coeruleus imaging could help to understand the contribution of locus coeruleus neurodegeneration to clinical and pathological manifestations in Alzheimer's disease, atypical neurodegenerative dementias and Parkinson's disease. Moreover, as the functional sensitivity of the noradrenergic system is likely to change with disease progression, in vivo measures of locus coeruleus integrity could provide new pathophysiological insights into cognitive and behavioural symptoms. Locus coeruleus imaging also holds the promise to stratify patients into clinical trials according to noradrenergic dysfunction. In this article, we present a consensus on how non-invasive in vivo assessment of locus coeruleus integrity can be used for clinical research in neurodegenerative diseases. We outline the next steps for in vivo, post-mortem and clinical studies that can lay the groundwork to evaluate the potential of locus coeruleus imaging as a biomarker for neurodegenerative diseases.

Identifiants

pubmed: 31327002
pii: 5536581
doi: 10.1093/brain/awz193
pmc: PMC6736046
doi:

Substances chimiques

Biomarkers 0
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2558-2571

Subventions

Organisme : NIA NIH HHS
ID : K24 AG053435
Pays : United States
Organisme : Medical Research Council
ID : MR/P012698/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P01271X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R006504/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103838
Pays : United Kingdom

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Comp Neurol. 2010 Apr 1;518(7):963-71
pubmed: 20127761
Nat Hum Behav. 2019 Nov;3(11):1203-1214
pubmed: 31501542
Arch Neurol. 2003 Mar;60(3):337-41
pubmed: 12633144
J Trace Elem Med Biol. 2014 Jan;28(1):1-7
pubmed: 24188895
Alzheimers Dement (Amst). 2019 Mar 27;11:281-285
pubmed: 30976648
Neurobiol Aging. 2018 Sep;69:167-176
pubmed: 29908415
Brain Res. 2011 Feb 10;1373:240-52
pubmed: 21147074
J Neuropathol Exp Neurol. 2018 Feb 1;77(2):149-161
pubmed: 29304218
JAMA Psychiatry. 2013 Nov;70(11):1199-1205
pubmed: 24048210
Ann Neurol. 1991 Oct;30(4):572-80
pubmed: 1789684
NPJ Parkinsons Dis. 2018 Jun 5;4:17
pubmed: 29900402
Neuropsychopharmacology. 2010 Jan;35(1):4-26
pubmed: 19812543
Brain. 2007 Dec;130(Pt 12):3297-307
pubmed: 18025031
Brain. 2018 Feb 1;141(2):496-504
pubmed: 29272343
Invest Radiol. 1989 Oct;24(10):794-804
pubmed: 2507476
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14835-14840
pubmed: 27930324
Neurobiol Aging. 2015 Feb;36(2):618-26
pubmed: 25433457
Antioxid Redox Signal. 2006 May-Jun;8(5-6):873-83
pubmed: 16771677
J Neurosci. 1981 Aug;1(8):876-86
pubmed: 7346592
Neurobiol Aging. 2016 Jan;37:117-126
pubmed: 26521135
Brain. 2016 Jul;139(Pt 7):2039-49
pubmed: 27190023
Mol Psychiatry. 2011 Jun;16(6):634-46
pubmed: 20386568
Neurology. 2018 Jan 9;90(2):74-82
pubmed: 29237794
Trends Neurosci. 2018 Apr;41(4):211-223
pubmed: 29475564
Nat Rev Neurosci. 2009 Mar;10(3):211-23
pubmed: 19190638
Curr Opin Behav Sci. 2018 Aug;22:14-20
pubmed: 31032387
J Neurosci. 2006 Jul 12;26(28):7416-23
pubmed: 16837589
Ann Neurol. 1992 Nov;32(5):667-76
pubmed: 1449247
Brain Struct Funct. 2019 May;224(4):1609-1625
pubmed: 30903359
Psychol Med. 1984 Feb;14(1):13-21
pubmed: 6709778
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
Brain Struct Funct. 2017 Dec;222(9):4203-4217
pubmed: 28647901
Brain. 1974 Sep;97(3):489-98
pubmed: 4423478
Sci Rep. 2017 Jun 29;7(1):4387
pubmed: 28663595
Neuroimage. 2018 Mar;168:427-436
pubmed: 28743460
Alzheimers Dement. 2017 Mar;13(3):236-246
pubmed: 27513978
Neuroimage. 2016 Sep;138:43-63
pubmed: 27181761
Neuroimage. 2015 Jun;113:235-45
pubmed: 25791783
Brain Pathol. 2016 May;26(3):371-86
pubmed: 26193084
Acta Neuropathol. 2008 Apr;115(4):437-44
pubmed: 18264713
Curr Opin Neurol. 2012 Dec;25(6):708-14
pubmed: 23160422
Neurobiol Aging. 2012 Aug;33(8):1651-63
pubmed: 21705113
J Neural Transm (Vienna). 2006 Jun;113(6):757-67
pubmed: 16755380
Magn Reson Med. 2019 Apr;81(4):2688-2701
pubmed: 30506939
Brain Res Brain Res Rev. 2003 Apr;42(1):33-84
pubmed: 12668290
Magn Reson Med Sci. 2006 Dec;5(4):197-200
pubmed: 17332710
Nat Commun. 2017 Oct 31;8(1):1214
pubmed: 29089479
Curr Opin Neurol. 2002 Aug;15(4):445-50
pubmed: 12151841
Ann Neurol. 2016 Feb;79(2):272-87
pubmed: 26583316
J Alzheimers Dis. 2018;62(4):1691-1702
pubmed: 29614677
J Neuroendocrinol. 1998 Oct;10(10):743-57
pubmed: 9792326
Neuroimage. 2015 May 15;112:7-13
pubmed: 25731994
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Front Neurosci. 2018 Jun 06;12:401
pubmed: 29928191
J Comp Neurol. 1989 Sep 15;287(3):373-92
pubmed: 2570794
Neurochem Int. 2010 Nov;57(4):375-82
pubmed: 20144675
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5108-5117
pubmed: 30796187
NPJ Parkinsons Dis. 2018 Apr 10;4:11
pubmed: 29644335
Brain. 2017 Nov 1;140(11):3023-3038
pubmed: 29053824
Clin Neuropathol. 2011 May-Jun;30(3):104-10
pubmed: 21545773
Alzheimers Dement (N Y). 2017 Aug 05;3(3):440-449
pubmed: 29067350
Lancet Neurol. 2018 Jul;17(7):618-628
pubmed: 29866443
J Neurosci. 2006 Feb 1;26(5):1343-54
pubmed: 16452658
Ann Neurol. 2015 Nov;78(5):787-800
pubmed: 26344059
Front Neurosci. 2013 Jun 10;7:95
pubmed: 23772204
Radiology. 1997 Aug;204(2):417-23
pubmed: 9240529
J Comp Neurol. 1991 Apr 15;306(3):480-94
pubmed: 1713927
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Neurobiol Aging. 2019 Feb;74:101-111
pubmed: 30447418
Mov Disord. 2014 Dec;29(14):1710-9
pubmed: 25297066
NMR Biomed. 2016 Apr;29(4):458-65
pubmed: 26835664
Magn Reson Med Sci. 2008;7(4):205-10
pubmed: 19110515
PLoS One. 2012;7(11):e48490
pubmed: 23139786
J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):261-76
pubmed: 15377733
Nat Neurosci. 2019 Feb;22(2):218-228
pubmed: 30643295
Magn Reson Med. 2018 Feb;79(2):1111-1115
pubmed: 28382642
MAGMA. 2017 Apr;30(2):121-125
pubmed: 27687624
Front Neurol. 2018 Jun 19;9:455
pubmed: 29971039
Neurobiol Aging. 1997 Jul-Aug;18(4):393-9
pubmed: 9330970
Neurobiol Aging. 2013 Jan;34(1):298-308
pubmed: 22743090
Trends Cogn Sci. 2016 Mar;20(3):214-226
pubmed: 26895736
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9843-8
pubmed: 15210960
Neurology. 2013 Sep 24;81(13):1122-9
pubmed: 23966253
Acta Neuropathol Commun. 2015 Feb 10;3:10
pubmed: 25853173
Magn Reson Med. 2014 Apr;71(4):1575-80
pubmed: 23716457
Brain Res. 1987 Jan 20;401(2):231-8
pubmed: 2434191
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409
pubmed: 22483313
Neuroreport. 2006 Jul 31;17(11):1215-8
pubmed: 16837857
Eur Neurol. 2013;70(1-2):70-7
pubmed: 23796701
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
Biol Psychiatry. 2015 Apr 15;77(8):740-8
pubmed: 24655598
Magn Reson Imaging. 2014 Dec;32(10):1301-6
pubmed: 25086330
Acta Neuropathol. 2008 Jun;115(6):629-34
pubmed: 18297292
Nature. 2016 Sep 15;537(7620):357-362
pubmed: 27602521
J Neurosci. 1988 May;8(5):1776-88
pubmed: 3367220
J Alzheimers Dis. 2018;66(1):115-126
pubmed: 30223398
Ann Neurol. 1999 Jan;45(1):82-91
pubmed: 9894881
Sci Transl Med. 2016 Jul 20;8(348):348ra96
pubmed: 27440727
Neurosci Biobehav Rev. 2017 Dec;83:325-355
pubmed: 29107830
Lancet Neurol. 2014 Oct;13(10):1045-60
pubmed: 25231526
Behav Brain Sci. 2016 Jan;39:e200
pubmed: 26126507
J Neurochem. 2016 Jul;138(2):339-53
pubmed: 27121280
Neurology. 2013 Mar 26;80(13):1202-8
pubmed: 23486878
Nat Rev Neurosci. 2016 Dec 15;18(1):57-65
pubmed: 27974841
Neurobiol Aging. 2003 Jan-Feb;24(1):1-23
pubmed: 12493547
J Neurosci. 2016 Jan 13;36(2):364-74
pubmed: 26758829
J Neurosci. 2018 Feb 7;38(6):1558-1574
pubmed: 29301874
Free Radic Biol Med. 1997;23(1):110-9
pubmed: 9165303
J Neurosci. 2018 Jan 3;38(1):74-92
pubmed: 29133432
Prog Neurobiol. 2017 Aug;155:96-119
pubmed: 26455458
Neuroscience. 2016 Dec 3;338:93-113
pubmed: 27267247
Annu Rev Neurosci. 2005;28:403-50
pubmed: 16022602
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2228-2233
pubmed: 29440429
J Neurochem. 2015 Nov;135(4):768-76
pubmed: 26156066
J Comp Neurol. 1995 Jul 17;358(1):79-87
pubmed: 7560278
Brain Pathol. 2015 Mar;25(2):121-35
pubmed: 24995389
Neurology. 2009 Nov 17;73(20):1699-704
pubmed: 19917994
Curr Sleep Med Rep. 2015 Mar;1(1):1-8
pubmed: 26618103
Magn Reson Imaging. 1990;8(4):417-22
pubmed: 2392030
Mov Disord. 2014 Jun;29(7):857-67
pubmed: 24753321
Neuroimage. 2017 Dec;163:150-159
pubmed: 28943414
Acta Neuropathol Commun. 2017 Jan 21;5(1):8
pubmed: 28109312
Exp Brain Res. 1989;77(2):257-70
pubmed: 2571514
Brain Res. 1981 Oct 5;222(1):43-64
pubmed: 7296272
J Neurosci Res. 2017 Jun;95(6):1336-1346
pubmed: 27685982
Neuropathol Appl Neurobiol. 2017 Aug;43(5):393-408
pubmed: 28117917
Brain. 2013 Jul;136(Pt 7):2120-9
pubmed: 23801736
Magn Reson Med. 2017 Nov;78(5):1790-1800
pubmed: 28019018
Alzheimers Res Ther. 2018 Feb 07;10(1):15
pubmed: 29415768
Neuroimage. 2009 Oct 1;47(4):1261-7
pubmed: 19524044
Alzheimers Res Ther. 2014 Jan 15;6(1):4
pubmed: 24423082
Neuropathol Appl Neurobiol. 2017 Aug;43(5):373-392
pubmed: 28117912

Auteurs

Matthew J Betts (MJ)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

Evgeniya Kirilina (E)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Center for Cognitive Neuroscience, Free University Berlin, Berlin, Germany.

Maria C G Otaduy (MCG)

Laboratory of Magnetic Resonance LIM44, Department and Institute of Radiology, Medical School of the University of São Paulo, Brazil.

Dimo Ivanov (D)

Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, MD, Maastricht, The Netherlands.

Julio Acosta-Cabronero (J)

Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.

Martina F Callaghan (MF)

Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.

Christian Lambert (C)

Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.

Arturo Cardenas-Blanco (A)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

Kerrin Pine (K)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.

Luca Passamonti (L)

Department of Clinical Neurosciences, University of Cambridge, UK.
Consiglio Nazionale delle Ricerche, Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Milan, Italy.

Clare Loane (C)

Institute of Cognitive Neuroscience, University College London, London, UK.

Max C Keuken (MC)

University of Amsterdam, Integrative Model-based Cognitive Neuroscience research unit, Amsterdam, The Netherlands.
University of Leiden, Cognitive Psychology, Leiden, The Netherlands.

Paula Trujillo (P)

Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.

Falk Lüsebrink (F)

Department of Biomedical Magnetic Resonance, Institute for Physics, Otto-von-Guericke-University, Magdeburg, Germany.
Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.

Hendrik Mattern (H)

Department of Biomedical Magnetic Resonance, Institute for Physics, Otto-von-Guericke-University, Magdeburg, Germany.

Kathy Y Liu (KY)

Division of Psychiatry, University College London, London, UK.

Nikos Priovoulos (N)

Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, The Netherlands.

Klaus Fliessbach (K)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Martin J Dahl (MJ)

Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany.

Anne Maaß (A)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Christopher F Madelung (CF)

Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Denmark.

David Meder (D)

Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Denmark.

Alexander J Ehrenberg (AJ)

Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA, USA.

Oliver Speck (O)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Department of Biomedical Magnetic Resonance, Institute for Physics, Otto-von-Guericke-University, Magdeburg, Germany.
Center for Behavioral Brain Sciences, Magdeburg, Germany.
Leibniz Institute for Neurobiology, Magdeburg, Germany.

Nikolaus Weiskopf (N)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.

Raymond Dolan (R)

Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.
Max Planck Centre for Computational Psychiatry and Ageing, University College London, UK.

Ben Inglis (B)

Henry H. Wheeler, Jr. Brain Imaging Center, University of California, Berkeley, CA, USA.

Duygu Tosun (D)

Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, USA.

Markus Morawski (M)

Paul Flechsig Institute of Brain Research, Medical Faculty, University of Leipzig, Leipzig, Germany.

Fabio A Zucca (FA)

Institute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy.

Hartwig R Siebner (HR)

Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Denmark.

Mara Mather (M)

Leonard Davis School of Gerontology and Department of Psychology, University of Southern California, Los Angeles, CA, USA.

Kamil Uludag (K)

Centre for Neuroscience Imaging Research, Institute for Basic Science and Department of Biomedical Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
Techna Institute and Koerner Scientist in MR Imaging, University Health Network, Toronto, Canada.

Helmut Heinsen (H)

University of São Paulo Medical School, São Paulo, Brazil.
Clinic of Psychiatry, University of Würzburg, Wurzburg, Germany.

Benedikt A Poser (BA)

Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, MD, Maastricht, The Netherlands.

Robert Howard (R)

Division of Psychiatry, University College London, London, UK.

Luigi Zecca (L)

Institute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy.
Department of Psychiatry, Columbia University Medical Center, New York State Psychiatric Institute, New York, USA.

James B Rowe (JB)

Department of Clinical Neurosciences, University of Cambridge, UK.

Lea T Grinberg (LT)

Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
University of São Paulo Medical School, São Paulo, Brazil.
Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.

Heidi I L Jacobs (HIL)

Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, MD, Maastricht, The Netherlands.
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, The Netherlands.

Emrah Düzel (E)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Institute of Cognitive Neuroscience, University College London, London, UK.

Dorothea Hämmerer (D)

Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology, London, UK.
Institute of Cognitive Neuroscience, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH